India Pharma 2026 to Boost Life Sciences Innovation

The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, Government of India, will host the 9th edition of India Pharma 2026 on 13–14 April in New Delhi. Organised in collaboration with the Federation of Indian Chambers of Commerce and Industry (FICCI) and the Indian Pharmaceutical Alliance (IPA), the event aims to strengthen India’s position as a global leader in pharmaceuticals and life sciences. It reflects the country’s strategic shift towards innovation-driven growth in healthcare.

Theme and strategic vision

The conference will be held under the theme “Discover in India: Leapfrogging Life-Sciences Innovation.” It emphasises India’s ambition to transition from a volume-based pharmaceutical industry to one driven by value, research and innovation. The theme aligns with national priorities of improving healthcare access, accelerating scientific advancement and enhancing global health security.

Focus areas and discussions

India Pharma 2026 will bring together policymakers, global industry leaders, researchers and innovators. Discussions will focus on emerging opportunities in drug discovery, complex generics and biosimilars. The platform will also highlight India’s growing capabilities in research and development, as well as its strength in pharmaceutical manufacturing. These areas are critical for strengthening India’s role in the global pharmaceutical value chain.

Role of institutions and industry bodies

FICCI, India’s oldest apex business organisation established in 1927, plays a key role in facilitating industry-government dialogue. With a wide membership base, it represents diverse sectors including multinational companies. The Indian Pharmaceutical Alliance contributes industry expertise, while the Department of Pharmaceuticals supports policy frameworks, infrastructure and innovation ecosystems to boost the sector.

Important Facts for Exams

• The Department of Pharmaceuticals functions under the Ministry of Chemicals and Fertilizers.
• FICCI was established in 1927 and is a major industry body in India.
• Biosimilars are biologic medical products similar to already approved biological medicines.
• ‘Viksit Bharat 2047’ is India’s long-term vision for becoming a developed nation.

Significance for India’s global role

India Pharma 2026 is a flagship initiative to promote India’s pharmaceutical capabilities and foster global collaboration. It aims to strengthen supply chains, encourage innovation and support self-reliance in healthcare. The event also aligns with the broader vision of Atmanirbhar Bharat by enhancing industry-academia partnerships and driving sustainable growth in the pharmaceutical and medtech sectors.